BioSpace News Archive

EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced the appointment of Daniel Adams as Chairman of the Board of Directors.

Theragun, Inc., the leader in hand-held percussive therapy devices, announced today that The Thunderbirds, hosts of the Waste Management Phoenix Open, have chosen Theragun as the official player gift for all PGA TOUR players participating in the 2020 Waste Management Phoenix Open golf tournament, being held January 27 through February 2, 2020 at the TPC Scottsdale.

Ningbo NewBay Medical Technology Co., Ltd. announced that it has entered into a licensing agreement with Genentech, a member of the Roche Group, under which it has been granted the exclusive global rights to further develop and commercialize GDC-0570, a small molecule Pan-PIM inhibitor that is active against multiple myeloma and prostate cancer in preclinical models.

The Board of Directors of BD has declared a quarterly dividend of $0.79 per common share, payable on March 31, 2020 to holders of record on March 10, 2020.

AIDS Foundation Houston Inc., a nonprofit dedicated to ending the HIV epidemic and supporting those affected by HIV, announces a new partnership with MISTR to provide convenient access to PrEP, or pre-exposure prophylaxis medication.

IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) announced today the pricing of an agency offering (the “Offering”) of up to 20,000,000 units, subject to a minimum offering of 10,000,000 units (the “Units”), for gross proceeds of between $5,000,000 and $10,000,000, assuming no exercise of the over-allotment option granted to the Agent (as defined below), at a price of $0.50 per Unit.